Curt Dewan

Curt Dewan, CFA is an experienced finance professional with a long career in the industry. Curt began their career in 2005 as an Investment Advisor for Edward Jones. In the same year, they also began working as a Financial Analyst for Canada Post. In 2010, they moved to Hertz as a Financial Planning Analyst. From 2011 to 2019, they held various roles at Shire, including Head of Financial Planning, Director of Corporate Finance, Head of Strategy & Operations, International Commercial, and Head of Finance - Central & Eastern Europe, Middle East & Africa. In 2019, they joined Servier Pharmaceuticals as a Business Development Executive, where they led the due diligence, valuation, and integration of the $1.8B acquisition of the Agios Oncology business. In 2021, they began working as Vice President, Head of Finance for Walden Biosciences.

Curt Dewan, CFA obtained a CAS in Management of Technology from EPFL (École polytechnique fédérale de Lausanne) in 2011. Curt then obtained an MSc in Biomechanics from McGill University in 2002-2004. Prior to that, they obtained a B.Ed in Kinesiology & Biology from McGill University in 1997-2001.